Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New class of compounds for drug-resistant HIV discovered at Pharmacor

Oct. 18, 2002

Novel HIV protease inhibitors identified at Pharmacor

Oct. 18, 2002

Clinical potential for WHI-05 and WHI-07 as contraceptive microbicides

Oct. 17, 2002

BMS patent covers novel anti-HIV agents

Oct. 16, 2002

Fuzeon, the first HIV fusion inhibitor, will receive a priority review at the FDA

Oct. 14, 2002

BG-777 completes phase I

Oct. 9, 2002

HIV-1 nucleocapsid zinc finger inhibitors validated as selective antiviral agents

Oct. 4, 2002

HIV RT inhibitors designed by team from Mayoly Spindler and U. of Geneva

Oct. 3, 2002

Triangle's Coviracil outperforms Zerit in phase III trial

Oct. 2, 2002

Phase III interim findings for protease inhibitor GW-433908 discussed in San Diego

Oct. 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...